These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 159330)

  • 1. Plasma androgens in congenital adrenal hyperplasia: androstenedione concentration as an index of adrenal androgen suppression.
    Keenan BS; McNeel R; Barrett GN; Holcombe JH; Kirkland RT; Clayton GW
    J Lab Clin Med; 1979 Nov; 94(5):799-808. PubMed ID: 159330
    [No Abstract]   [Full Text] [Related]  

  • 2. Variable efficacy of glucocorticoids in congenital adrenal hyperplasia.
    Hansen JW; Loriaux DL
    Pediatrics; 1976 Jun; 57(6):942-7. PubMed ID: 934750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen studies in virilism secondary to an adrenal adenoma and to congenital adrenal hyperplasia.
    Osborn RH; Yannone ME; Bradbury JT
    Obstet Gynecol; 1969 May; 33(5):658-65. PubMed ID: 4238091
    [No Abstract]   [Full Text] [Related]  

  • 4. Androgen metabolism in congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency.
    Frasier SD; Horton R; Ulstrom RA
    Pediatrics; 1969 Aug; 44(2):201-8. PubMed ID: 5806251
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma progesterone, 17-hydroxyprogesterone, androstenedione and testosterone in prepubertal, pubertal and adult subjects with congenital virilizing adrenal hyperplasia as indicators of adrenal suppression.
    Lee PA; Urban MD; Gutai JP; Migeon CJ
    Horm Res; 1980; 13(6):347-57. PubMed ID: 7196877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hirsutism and hyperandrogenism.
    Givens JR
    Adv Intern Med; 1976; 21():221-47. PubMed ID: 130060
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum androgens as a continuing index of adequacy of treatment of congenital adrenal hyperplasia.
    Korth-Schutz S; Virdis R; Saenger P; Chow DM; Levine LS; New MI
    J Clin Endocrinol Metab; 1978 Mar; 46(3):452-8. PubMed ID: 156192
    [No Abstract]   [Full Text] [Related]  

  • 8. [Value of the assay of plasma steroids in the control of congenital adrenal hyperplasia].
    Theintz GE; Sizonenko PC
    Arch Fr Pediatr; 1985 Mar; 42(3):211-7. PubMed ID: 4004483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Urinary excretion of pregnanetriol in various internal diseases].
    Nagano T
    Nihon Naibunpi Gakkai Zasshi; 1966 Dec; 42(9):1035-47. PubMed ID: 4291583
    [No Abstract]   [Full Text] [Related]  

  • 10. Dose-response comparison between dexamethasone and 16-methylene-6-dehydrocortisol in the short-term suppression test.
    Gillich KH; Krüskemper HL
    Horm Metab Res; 1970 Mar; 2(2):106-9. PubMed ID: 4329445
    [No Abstract]   [Full Text] [Related]  

  • 11. [Metabolism of estrogens in the adrenogenital syndrome].
    Serrera Contreras JL
    Rev Iber Endocrinol; 1974 May; 21(123):217-38. PubMed ID: 4837978
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum androgen concentrations in neonates and young infants with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Pang S; Levine LS; Chow DM; Faiman C; New MI
    Clin Endocrinol (Oxf); 1979 Dec; 11(6):575-84. PubMed ID: 161209
    [No Abstract]   [Full Text] [Related]  

  • 13. 3 alpha-androstanediol glucuronide in virilizing congenital adrenal hyperplasia: a useful serum metabolic marker of integrated adrenal androgen secretion.
    Pang S; MacGillivray M; Wang M; Jeffries S; Clark A; Rosenthal I; Wiegensberg M; Riddick L
    J Clin Endocrinol Metab; 1991 Jul; 73(1):166-74. PubMed ID: 2045467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary and serum steroid concentrations in the management of congenital adrenal hyperplasia. Lack of physiologic correlations.
    Hendricks SA; Lippe BM; Kaplan SA; Lavin N; Mayes DM
    Am J Dis Child; 1982 Mar; 136(3):229-32. PubMed ID: 7064949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of plasma androstenedione in monitoring therapy of patients with congenital adrenal hyperplasia.
    Cavallo A; Corn C; Bryan GT; Meyer WJ
    J Pediatr; 1979 Jul; 95(1):33-7. PubMed ID: 480011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pregnanetriolone and the adrenogenital syndrome].
    Lohmeyer H
    Bibl Gynaecol; 1970; 53():1-98. PubMed ID: 5437131
    [No Abstract]   [Full Text] [Related]  

  • 17. Androgen production in boys with sexual precocity and congenital adrenal hyperplasia.
    Levine LS; New MI; Pitt P; Peterson RE
    Metabolism; 1972 May; 21(5):457-64. PubMed ID: 4335735
    [No Abstract]   [Full Text] [Related]  

  • 18. Androstenedione and its conversion to plasma testosterone in congenital adrenal hyperplasia.
    Horton R; Frasier SD
    J Clin Invest; 1967 Jun; 46(6):1003-9. PubMed ID: 4290686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum 17-alpha-hydroxyprogesterone, progesterone, estradiol, and testosterone in the diagnosis and management of congenital adrenal hyperplasia.
    Lippe BM; LaFranchi SH; Lavin N; Parlow A; Coyotupa J; Kaplan SA
    J Pediatr; 1974 Dec; 85(6):782-7. PubMed ID: 4371221
    [No Abstract]   [Full Text] [Related]  

  • 20. Diagnosis of congenital adrenal hyperplasia with 11-hydroxylase deficiency by determination of tetrahydro-11-desoxycortisol in urine.
    Knorr D; Bidlingmaier F
    Helv Paediatr Acta; 1974; Suppl 34():119-25. PubMed ID: 4452634
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.